193
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Amyotrophic lateral sclerosis mortality rates among ethnic groups in a predominant admixed population in Latin America: a population-based study in Ecuador

ORCID Icon, , ORCID Icon, , , , & show all
Pages 404-412 | Received 28 Dec 2018, Accepted 17 Feb 2019, Published online: 02 Apr 2019

References

  • Marin B, Couratier P, Arcuti S, Copetti M, Fontana A, Nicol M, et al. Stratification of ALS patients’ survival: a population-based study. J Neurol. 2016;263:100–11.
  • Luna J, Logroscino G, Couratier P, Marin B. Current issues in ALS epidemiology: variation of ALS occurrence between populations and physical activity as a risk factor. Rev Neurol (Paris). 2017;173:244–53.
  • Marin B, Couratier P, Preux PM, Logroscino G. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology. 2011;36:29–38.
  • Marin B, Boumédiene F, Logroscino G, Couratier P, Babron MC, Leutenegger AL, et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol. 2017;46:57–74.
  • Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007;68:1002–7.
  • Logroscino G, Piccininni M, Marin B, Nichols E, Abd-Allah F, Abdelalim A, et al. Global, regional, and national burden of motor neuron diseases 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:1083–97.
  • Noonan CW, White MC, Thurman D, Wong LY. Temporal and geographic variation in United States motor neuron disease mortality, 1969–1998. Neurology. 2005;64:1215–21.
  • Leone M, Chandra V, Schoenberg BS. Motor neuron disease in the United States, 1971 and 1973-1978: patterns of mortality and associated conditions at the time of death. Neurology. 1987;37:1339–43.
  • Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology. 2009;72:1640–5.
  • Bucheli M, Andino A, Montalvo M, Cruz J, Atassi N, Berry J, et al. Amyotrophic lateral sclerosis: analysis of ALS cases in a predominantly admixed population of Ecuador. Amyotroph Lateral Scler Front Degener. 2014;15:106–13.
  • Olivares L, Estéban ES, Alter M. Mexican “resistance” to amyotrophic lateral sclerosis. Arch Neurol. 1972;27:397–402.
  • The World Bank Group. Country income groups (World Bank classification), country and lending groups. [Internet]. 2018. Available at: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups.
  • Instituto Nacional de Estadística y Censos. Censo de Población y Vivienda [Internet]. Available at: http://www.ecuadorencifras.gob.ec/base-de-datos-censo-de-poblacion-y-vivienda/.
  • World Health Organization. International statistical classification of diseases and related health problems. Vol. 2. Instruction manual. 10th revision. Geneva, Switzerland: World Health Organization; 2010.
  • Villacís B, Carrillo D. Estadística demográfica en el Ecuador: diagnostico y propuesta. San José, CA: Instituto Nacional de Estad´ıstica y Censos (INEC); 2011.
  • The United Nations Statistics Division. Demographic and social statistics [Internet]. Available at: https://unstats.un.org/unsd/demographic-social/products/dyb/.
  • Bennett DA, Brayne C, Feigin VL, Barker-Collo S, Brainin M, Davis D, et al. Development of the Standards of Reporting of Neurological Disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology. Neurology. 2015;85:821–8.
  • Vandenbroucke JP, Elm EV, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4:e297.
  • US Census Bureau. Census data products: United States. 2010. [Internet]. Available at: http://www.census.com/.
  • Instituto Nacional de Estadística y Censos. Población y Demografía. [Internet]. Available at: http://www.ecuadorencifras.gob.ec/censo-de-poblacion-y-vivienda/.
  • SAS/STAT(R) 14.1 User’s Guide. Comparing directly standardized rates; 2015.
  • Marin B, Logroscino G, Boumédiene F, Labrunie A, Couratier P, Babron MC, et al. Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol. 2016;31:229–45.
  • Marin B, Fontana A, Arcuti S, Copetti M, Boumédiene F, Couratier P, et al. Age-specific ALS incidence: a dose-response meta-analysis. Eur J Epidemiol. 2018;33:621–34.
  • Logroscino G, Traynor BJ, Hardiman O, Chio’ A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6–11.
  • Seljeseth YM, Vollset SE, Tysnes OB. Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology. 2000;55:1262–6.
  • Nakken O, Lindstrøm JC, Tysnes OB, Holmøy T. Mortality trends of amyotrophic lateral sclerosis in Norway 1951–2014: an age-period-cohort study. J Neurol. 2016;263:2378–85.
  • Seals RM, Hansen J, Gredal O, Weisskopf MG. Age-period-cohort analysis of trends in amyotrophic lateral sclerosis in Denmark, 1970–2009. Am J Epidemiol. 2013;178:1265–71.
  • Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology. 2008;71:1889–95.
  • Valenzuela D, Zitko P, Lillo P. Amyotrophic lateral sclerosis mortality rates in Chile: a population based study (1994–2010). Amyotroph Lateral Scler Front Degener. 2015;16:372–7.
  • Del Brutto VJ, Tettamanti D, Del Brutto OH. Changing profile of 7,519 neurologic outpatients evaluated over 20 years. Eur Neurol. 2012;68:381–90.
  • Arthur KC, Calvo A, Price TR, Geiger JT, Chiò A, Traynor BJ. Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun. 2016;7:12408.
  • Galdames D, Aguilera L, Riveros JM, Arce C. [Epidemiology of amyotrophic lateral sclerosis in Santiago. A retrospective study (author’s transl)]. Rev Med Chil. 1980;108:435–9.
  • Matos SED, Conde MTRP, Fávero FM, Taniguchi M, Quadros AAJ, Fontes SV, et al. Mortality rates due to amyotrophic lateral sclerosis in São Paulo city from 2002 to 2006. Arq Neuro-Psiquiatr. 2011;69:861–6.
  • McCluskey K, McCluskey L. Racial disparity in mortality from ALS/MND in US African Americans. Amyotroph Lateral Scler Mot Neuron Disord. 2004;5:73–8.
  • Rechtman L, Jordan H, Wagner L, Horton DK, Kaye W. Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States. Amyotroph Lateral Scler Front Degener. 2015;16:65–71.
  • Valle J, Roberts E, Paulukonis S, Collins N, English P, Kaye W. Epidemiology and surveillance of amyotrophic lateral sclerosis in two large metropolitan areas in California. Amyotroph Lateral Scler Front Degener. 2015;16:209–15.
  • Roberts AL, Johnson NJ, Chen JT, Cudkowicz ME, Weisskopf MG. Race/ethnicity, socioeconomic status, and ALS mortality in the United States. Neurology. 2016;87:2300–8.
  • Homburger JR, Moreno-Estrada A, Gignoux CR, Nelson D, Sanchez E, Ortiz-Tello P, et al. Genomic insights into the ancestry and demographic history of South America. PLoS Genet. 2015;11:e1005602.
  • Santangelo R, González-Andrade F, Børsting C, Torroni A, Pereira V, Morling N. Analysis of ancestry informative markers in three main ethnic groups from Ecuador supports a trihybrid origin of Ecuadorians. Forensic Sci Int Genet. 2017;31:29–33.
  • Montenegro RA, Stephens C. Indigenous health in Latin America and the Caribbean. Lancet. 2006;367:1859–69.
  • Royal CD, Novembre J, Fullerton SM, Goldstein DB, Long JC, Bamshad MJ, et al. Inferring genetic ancestry: opportunities, challenges, and implications. Am J Hum Genet. 2010;86:661–73.
  • Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88:540–9.
  • Stickler DE, Royer JA, Hardin JW. Accuracy and usefulness of ICD-10 death certificate coding for the identification of patients with ALS: results from the South Carolina ALS surveillance pilot project. Amyotroph Lateral Scler. 2012;13:69–73.
  • Dean G, Quigley M, Goldacre M. Motor neuron disease in a defined English population: estimates of incidence and mortality. J Neurol Neurosurg Psychiatry. 1994;57:450–4.
  • Fong KY, Yu YL, Chan YW, Kay R, Chan J, Yang Z, et al. Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture. Neuroepidemiology. 1996;15:239–45.
  • Thygesen LC, Ersbøll AK. When the entire population is the sample: strengths and limitations in register-based epidemiology. Eur J Epidemiol. 2014;29:551–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.